c.vermeulen
TL2 Moderator · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 27 April 2025 · last posted 16d
77 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #17 · Outcomes › Progress reports · 12 Jul 2026 · 2 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #71 · Start Here › Welcome · 9 Jul 2026 · 0 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #71 · Wellbeing › Sleep · 28 Jun 2026 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Aggregate verification data across the directory, with caveats Replied, post #8 · Sourcing › Independent verification · 22 Jun 2026 · 4 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #70 · Compounds › Repair & healing peptides · 11 Jun 2026 · 0 likes On post #66 — agreed on the reasoning, with one qualification. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one…
-
Why the timeline is on the right and not the left — what changed since Replied, post #46 · Meta › Site feedback · 31 May 2026 · 0 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #49 · Sourcing › Red flags · 20 May 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Official shortage notices and what they authorise Replied, post #55 · Access › Shortages · 18 May 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Does a peptide degrade silently, with no visual change? Replied, post #27 · Practice › Storage & stability · 14 May 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #65 · Sourcing › Logistics · 9 May 2026 · 13 likes On post #61 — agreed on the reasoning, with one qualification. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #4 · Evidence › Trials · 5 May 2026 · 11 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Reading a home test result without over-claiming Replied, post #27 · Analytics › Home & field testing · 30 Apr 2026 · 0 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Journal club: is percentage weight change the right endpoint? Replied, post #77 · Evidence › Journal club · 17 Apr 2026 · 6 likes post #76 answers the question as asked. The question underneath it is different. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference…
-
Why this subcategory is stricter about sourcing than most Replied, post #18 · Compounds › Secretagogues & GH axis · 14 Apr 2026 · 3 likes Picking up post #15: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Fixed versus detachable needles: the trade-offs — does this still hold? Started this topic · Devices › Syringes & needles · 11 Apr 2026 · 3 likes Fixed versus detachable needles: the trade-offs — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. A…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #78 · Compounds › Tirzepatide · 11 Apr 2026 · 4 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Solubility limits and what a cloudy solution is telling you Replied, post #7 · Pharmacology › Formulation chemistry · 10 Apr 2026 · 4 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #82 · Start Here › How to Ask · 6 Apr 2026 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
GLP-1 receptor distribution: central and peripheral Replied, post #26 · Pharmacology › Receptor biology · 4 Apr 2026 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #47 · Outcomes › Body composition · 25 Mar 2026 · 0 likes post #46 is right about the mechanism and I think understates the practical bit. Bioelectric impedance analysis: less precise than DXA and strongly affected by…
-
Revisiting: Maintainer handover: how it works Replied, post #44 · Meta › Wiki maintenance · 11 Mar 2026 · 5 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #7 · Pharmacology › Formulation chemistry · 8 Mar 2026 · 17 likes post #6 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #4 · Lounge › Introductions · 6 Mar 2026 · 29 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
Managing an unplanned gap in supply Replied, post #9 · Access › Shortages · 19 Jan 2026 · 21 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #14 · Practice › Storage & stability · 17 Jan 2026 · 12 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #32 · Documentation › Wiki requests · 10 Jan 2026 · 3 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
A partial dose because the pen emptied mid-injection Replied, post #41 · Practice › Administration · 8 Jan 2026 · 11 likes Coming back to post #39, because the follow-up matters more than the original answer. Injecting into an area that has become firm: lipohypertrophy — thickened fatty…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #37 · Practice › Dosing & titration · 4 Jan 2026 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #13 · Data & Tools › Calculators · 31 Dec 2025 · 1 like Coming back to post #11, because the follow-up matters more than the original answer. The calculators maintained on this site are open-source and verifiable. They are…
-
MHRA statements, read directly Replied, post #54 · Regional › UK & Ireland · 23 Dec 2025 · 4 likes I read post #52 twice before replying, because I had assumed the opposite. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and…
-
Aggregates and why a purity assay may miss them entirely Replied, post #23 · Analytics › Impurities & related substances · 23 Dec 2025 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears…
-
Realistic expectations for strength while losing weight quickly Replied, post #40 · Nutrition & Training › Resistance training · 29 Nov 2025 · 0 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…
-
Prescription requirements and telehealth models Replied, post #37 · Sourcing › Regulatory · 29 Nov 2025 · 32 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #39 · Sourcing › Vendor reports · 26 Nov 2025 · 14 likes post #38 is right about the mechanism and I think understates the practical bit. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
Injection discomfort: needle gauge, volume, temperature, technique Started this topic · Practice › Administration · 24 Nov 2025 · 19 likes Injection discomfort: needle gauge, volume, temperature, technique — setting out what I have, and where I think it stops being reliable. Practical question with the…
-
A history of disordered eating: proceeding carefully Replied, post #10 · Wellbeing › Mental health · 22 Nov 2025 · 26 likes post #9 answers the question as asked. The question underneath it is different. Body image and weight loss: large weight loss changes a person's relationship with their…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #23 · Meta › Announcements · 21 Nov 2025 · 2 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #117 · Start Here › How to Ask · 19 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Documentation that appears only after payment Replied, post #79 · Sourcing › Red flags · 17 Nov 2025 · 5 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
[2026 update] What steady state means for the decision to escalate Replied, post #115 · Practice › Dosing & titration · 17 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Lurking for two months before posting: was that the right call? Replied, post #6 · Start Here › Welcome · 16 Nov 2025 · 17 likes I read post #4 twice before replying, because I had assumed the opposite. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly…
-
[2026 update] What steady state means for the decision to escalate Replied, post #80 · Practice › Dosing & titration · 13 Nov 2025 · 0 likes On post #76 — agreed on the reasoning, with one qualification. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them…
-
EMA product information as a primary source Replied, post #57 · Regional › European Union · 12 Nov 2025 · 31 likes On post #53 — agreed on the reasoning, with one qualification. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight…
-
Payment mechanics and the recovery options that do not exist Replied, post #19 · Sourcing › Payments · 19 Oct 2025 · 5 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #101 · Practice › Side effects · 28 Sep 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #63 · Compounds › Semaglutide · 23 Sep 2025 · 25 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Titles that describe the question, not the situation Replied, post #103 · Start Here › How to Ask · 23 Sep 2025 · 9 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Reading SURMOUNT-1 without the press release Replied, post #13 · Compounds › Tirzepatide · 20 Sep 2025 · 0 likes On post #9 — agreed on the reasoning, with one qualification. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did…
-
"Should I double up?" — answered once, at length, calmly Replied, post #15 · Practice › Administration · 31 Aug 2025 · 4 likes Picking up post #12: that is the part I would want checked first. Drawing up with one needle and injecting with another: a reasonable practice if you have extra…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #82 · Compounds › Secretagogues & GH axis · 20 Aug 2025 · 11 likes post #81 answers the question as asked. The question underneath it is different. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #18 · Practice › Storage & stability · 9 Aug 2025 · 30 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Washout: how long is long enough, and for what purpose Replied, post #49 · Pharmacology › Pharmacokinetics · 26 Jul 2025 · 18 likes Worth separating two things that post #45 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
An appeal that failed, and what I would do differently Replied, post #6 · Access › Insurance & coverage · 23 Jun 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #88 · Practice › Reconstitution · 9 Jun 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #15 · Practice › Administration · 8 Jun 2025 · 24 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #22 · Access › Insurance & coverage · 8 Jun 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #114 · Devices › Cold chain · 1 Jun 2025 · 7 likes This follows post #111 rather than contradicting it. Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive…
-
Particulates in a reconstituted solution: identifying the likely source — what changed… Replied, post #3 · Analytics › Impurities & related substances · 21 May 2025 · 10 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Lean mass preservation: what the evidence supports Replied, post #6 · Outcomes › Body composition · 7 May 2025 · 11 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 29 Mar 2025 · 12 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
Criticising the method without criticising the authors Replied, post #51 · Evidence › Study critique · 29 Mar 2025 · 1 like post #50 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Albumin binding and how it produces a long half-life Replied, post #18 · Pharmacology › Pharmacokinetics · 26 Mar 2025 · 22 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Reading order for a first week here, and what to skip until later Replied, post #45 · Start Here › Welcome · 20 Mar 2025 · 22 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Adjudicated events and why the definition matters — the long version Replied, post #39 · Evidence › Trials · 8 Mar 2025 · 0 likes Picking up post #36: that is the part I would want checked first. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false…
-
Assessing a warm arrival: the decision process Replied, post #9 · Sourcing › Logistics · 3 Mar 2025 · 18 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #23 · Access › International · 1 Feb 2025 · 0 likes post #22 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Body image changing more slowly than the body Replied, post #92 · Wellbeing › Mental health · 21 Dec 2024 · 3 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #71 · Practice › Side effects · 14 Dec 2024 · 24 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
[2026 update] New subcategory: rationale and scope Replied, post #57 · Meta › Announcements · 11 Dec 2024 · 6 likes post #56 answers the question as asked. The question underneath it is different. Notifications: watching this subcategory means you receive notifications when…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #39 · Access › Insurance & coverage · 24 Nov 2024 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Converting between mg/mL and units per dose, both directions Replied, post #76 · Practice › Reconstitution · 4 Nov 2024 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #8 · Start Here › Welcome · 2 Oct 2024 · 14 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Tracking a preprint to publication: a worked example — the long version Replied, post #32 · Evidence › Preprints · 31 Aug 2024 · 4 likes post #31 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #12 · Analytics › Impurities & related substances · 27 Aug 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Naming conventions for research peptides and the confusion they cause — one year on Replied, post #5 · Compounds › Other compounds · 28 Jul 2024 · 6 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #22 · Practice › Dosing & titration · 16 Jun 2024 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Spreadsheets: an appreciation Replied, post #14 · Lounge › Off topic · 7 Jun 2024 · 31 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.